Gsk Share Discussion Threads

[montyhedge] 05/5/2009 08:47

Could do, but who cares dividend cheque drops on the doormat every 12 weeks and growing at 8% pa.

[lord luc4n] 05/5/2009 08:37

£9 very soon chaps

[montyhedge] 05/5/2009 08:19

Sat
Your right, investors want risk, like banks etc, no deaths outside Mexico, but schools uk 6 now shut, they reckon if L6 then 40% of workforced off work.

[sat69] 05/5/2009 08:15

Punters avoiding defensives. Flu is spreading but no further deaths outside Mexico.

[montyhedge] 05/5/2009 07:54

Maddoff, bears in control, Relenza made £888m without swine flu, now production stepped up and if it goes to L6 then £1.6 billion pa.

[madoff with cash] 05/5/2009 07:48

cd we see below tenner, monty?

[montyhedge] 05/5/2009 06:38

Oneeyejack
Yes and dividend growing at 8% a year, paid quarterly. Great for income seekers.

[montyhedge] 05/5/2009 06:32

Worst is yet to come, according to gov.

[montyhedge] 05/5/2009 06:26

Swine flu spreading, may not kill anyone outside Mexico, but UK, 5 schools shut today, 40% of the workforce could be off work in a few months time if not stopped. GSK priced wrong should be well over 1150p.

[oneeyedjack01] 05/5/2009 06:24

Dividend paid quarterly. :-)

Regular income + up from here = very nice thanks

[coffeelito] 05/5/2009 00:20

every 12 weeks ??!

[diku] 04/5/2009 18:52

monty...you know I was only joking...bank bonds have already spiked up as well..all the hallmarks of a switch over out of financials, retailers and into defensive is probably under way...

[montyhedge] 04/5/2009 18:45

diku
Cheque drops on the doormat every 12 weeks from GSK, no dividend for the banks for years. Buy bank corporate bonds I have.

[diku] 04/5/2009 18:42

Punters want money now...not yearly...by then another bubble gets burst...Barc is providing punters with free money now!...

[montyhedge] 04/5/2009 18:39

Dividend is 60p a year for the coming year, not bad, paid quarterly best income stock in the FTSE 100. The growth is in the dividend growing at 8% per year.

[wongauk] 04/5/2009 18:33

ONCOLOGIC DRUGS ADVISORY COMMITTEE

DATE: May 29, 0800/1200

LOCATION: Rosen Shingle Creek, 9939 Universal Blvd., Orlando, Fla.

CONTACT: Nicole Vesely, 301-827-6793

The committee will discuss an a biologics license application from GlaxoSmithKline Plc for Arzerra, known generically as ofatumumab, for the proposed indication of treatment of patients with chronic lymphocytic leukemia who have received prior therapy. The drug is being developed with Genmab A/S.

[oilgetmecoat] 04/5/2009 11:31

I would like to add my pennys worth. I am investing for the longterm because I believe GSK are (finally) making the difficuly, but right choices for the future. The Massive layoffs across R&D are necessary to lower overheads in hight cost centers. Outsourcing to India and China are the consequence of this, and a good move in my opinion. The deal with Pfizer is great news because HIV combinations will be delivered quicker and cheaper to the market under the unbrella of one company. The Stiefl deal helps to diversify into OTC market where GSK now has a very strong presence. Are you getting the picture now? I would spend some time looking at their pipeline of drugs as well, not just focus on patent expiry/generic competition. GSK will survive patent expiries over next few years and become a multi-bagger IMO. I will hold these for retirement, happy to take dividends until then and accummulate around £10. Good luck all

[oneeyedjack01] 04/5/2009 08:48

News sources are talking about the possibility of the virus crossing back and forth from pigs to humans mutating along the way. If this happens real problems will occur and the share price of GSK wont be a great concern. Economic downturn, too many people, will say it again it's far too convenient for my liking.

[spondon] 04/5/2009 07:52

I'm a long term holder on GSK(certs not cfds/spreadbets)so happy to just take divis, share price therefore fairly irrelevant.It's intersting to see how stories effect GSK like Avandia, they don't seem to be ranting about that now, but as you say they are defensive and fund managers will pull money out if they can double it on a volatile short squeezer

[oneeyedjack01] 04/5/2009 07:26

Spondon,

I think we are close to the point where the market is going to turn.
If the market does turn you see this stock going up because quite simply it is a defensive one? Also am I right seeing a sort of inverse relationship with the FTSE?

GSK will get some benefit from the Flu but Wonga is right on the long term reasons for this stock but having said that if the flu kicks of the FTSE etc going back down again which it very well could GSK could benefit in that way.

I could sell tomorrow for no real loss but to be honest right at this point this is the exact sort of stock I want to be in. The financial sector has gone too far and many energy co's have had a good rise.

We will have to see but in three months time I am sure buying GSK at this level will prove to be a smart move. I cannot understand why anyone would want to be short at this price, it might go down a bit but most of the profit has been had and people would be well placed to go long now.

Regards.

[wongauk] 03/5/2009 20:48

Spondon - Tamiflu does have side effects. This is a known fact..... shame that lol :-)